First Trust Advisors
RCUS icon

First Trust Advisors’s Arcus Biosciences RCUS Stock Holding History

First Trust Advisors’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.37M Buy
271,434
+258,336
+1,972% +$6.38M ﹤0.01% 1298
2026
Q1 		$283K Buy
+13,098
New +$283K ﹤0.01% 2483
2025
Q1 		– Sell
-17,708
Closed -$264K – 2606
2024
Q4 		$264K Buy
17,708
+5,337
+43% +$87.2K ﹤0.01% 2410
2024
Q3 		$189K Buy
12,371
+1,796
+17% +$28.3K ﹤0.01% 2321
2024
Q2 		$161K Buy
+10,575
New +$171K ﹤0.01% 2273
2023
Q2 		– Sell
-15,845
Closed -$289K – 2431
2023
Q1 		$289K Sell
15,845
-83,839
-84% -$1.6M ﹤0.01% 2245
2022
Q4 		$2.06M Buy
99,684
+14,924
+18% +$411K ﹤0.01% 1689
2022
Q3 		$2.22M Buy
84,760
+14,110
+20% +$373K ﹤0.01% 1637
2022
Q2 		$1.79M Buy
70,650
+18,761
+36% +$459K ﹤0.01% 1770
2022
Q1 		$1.64M Sell
51,889
-106,838
-67% -$3.58M ﹤0.01% 1847
2021
Q4 		$6.42M Buy
158,727
+138,808
+697% +$5.38M 0.01% 1237
2021
Q3 		$695K Sell
19,919
-84,659
-81% -$2.63M ﹤0.01% 2169
2021
Q2 		$2.87M Sell
104,578
-36,519
-26% -$1.04M ﹤0.01% 1668
2021
Q1 		$3.96M Buy
141,097
+92,147
+188% +$3.21M ﹤0.01% 1376
2020
Q4 		$1.27M Buy
+48,950
New +$1.18M ﹤0.01% 1794

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

First Trust Advisors's RCUS Position: Q2 2026 in Review

First Trust Advisors increased its Arcus Biosciences (RCUS) stake by 1,972% in Q2 2026, buying an estimated $6.38M and bringing the position to 271,434 shares worth $8.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1298.

First Trust Advisors first reported a position in RCUS in Q4 2020 and has held it in 15 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • First Trust Advisors held 271,434 shares of Arcus Biosciences worth $8.37M as of Q2 2026.
  • First Trust Advisors bought 258,336 Arcus Biosciences shares in Q2 2026, an estimated $6.38M.
  • Arcus Biosciences made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1298 holding.
  • First Trust Advisors first reported a position in Arcus Biosciences in Q4 2020 and has held it in 15 quarters since.
  • 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.